Mark T Drayson (M T Drayson, Mark Drayson)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 18

Top Venues

Blood cancer journal

British journal of haematology

European journal of haematology

Leukemia

University of Birmingham

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Birmingham Aug 01 1990

United Kingdom

Professor Clinical Immunodiagnostics :: Institute of Immunology and Immunotherapy

Publications

Hannah V Giles, Mark T Drayson, B Kishore, Charlotte Pawlyn, Martin F Kaiser, Curly T C M Morris, R de Tute, R G Owen, David A Cairns, T Menzies, F E Davies, G J Morgan, Guy Pratt, G H Jackson
Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry. Blood cancer journal 14 (1) (2024)
Mark T Drayson, Tom Jennis, Ira Laketic-Ljubojevic, Dina Patel, Guy Pratt, Suzanne Renwick, Alex Richter, Rachel Wheeler, Joanna Sheldon, Ross Sadler, Mary Stapleton, Fenella Willis, Mairi Whiston, null null
Laboratory practice is central to earlier myeloma diagnosis: Utilizing a primary care diagnostic tool and laboratory guidelines integrated into haematology services. British journal of haematology 204 (2) (2024)
Mark T Drayson, Tom Jennis, Ira Laketic-Ljubojevic, Dina Patel, Guy Pratt, Suzanne Renwick, Alex Richter, Rachel Wheeler, Joanna Sheldon, Ross Sadler, Mary Stapleton, Fenella Willis, Mairi Whiston, null null
Laboratory practice is central to earlier myeloma diagnosis: Utilizing a primary care diagnostic tool and laboratory guidelines integrated into haematology services. British journal of haematology (2024)
Mark T Drayson, Tom Jennis, Ira Laketic-Ljubojevic, Dina Patel, Guy Pratt, Suzanne Renwick, Alex Richter, Rachel Wheeler, Joanna Sheldon, Ross Sadler, Mary Stapleton, Fenella Willis, Mairi Whiston, null null
Laboratory practice is central to earlier myeloma diagnosis: Utilizing a primary care diagnostic tool and laboratory guidelines integrated into haematology services. British journal of haematology 204 (2) (2024)
Mark T Drayson, Tom Jennis, Ira Laketic-Ljubojevic, Dina Patel, Guy Pratt, Suzanne Renwick, Alex Richter, Rachel Wheeler, Joanna Sheldon, Ross Sadler, Mary Stapleton, Fenella Willis, Mairi Whiston, null null
Laboratory practice is central to earlier myeloma diagnosis: Utilizing a primary care diagnostic tool and laboratory guidelines integrated into haematology services. British journal of haematology 204 (2) (2024)
Hannah V Giles, Mark T Drayson, B Kishore, Charlotte Pawlyn, Martin F Kaiser, Curly T C M Morris, R de Tute, R G Owen, David A Cairns, T Menzies, F E Davies, G J Morgan, Guy Pratt, G H Jackson
Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry. Blood cancer journal 14 (1) (2024)
Sian E Faustini, Y L Tracey Chan, Lilli Evans, Emily Collman, Alec Rapson, Claire Backhouse, Annabelle Emery, John P Campbell, Sally Moore, Alex Richter, Guy Pratt, Mark T Drayson, Jennifer L J Heaney
Plasma cell disorders supress mucosal anti-bacterial immunity: another dimension of immunoparesis in plasma cell neoplasms. Leukemia (2024)
Hannah V Giles, Mark T Drayson, B Kishore, Charlotte Pawlyn, Martin F Kaiser, Curly T C M Morris, R de Tute, R G Owen, David A Cairns, T Menzies, F E Davies, G J Morgan, Guy Pratt, G H Jackson
Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry. Blood cancer journal 14 (1) (2024)
Hannah V Giles, Mark T Drayson, B Kishore, Charlotte Pawlyn, Martin F Kaiser, Curly T C M Morris, R de Tute, R G Owen, David A Cairns, T Menzies, F E Davies, G J Morgan, Guy Pratt, G H Jackson
Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry. Blood cancer journal 14 (1) (2024)
Clement Twumasi, Sally Moore, Ross Sadler, Sally Jeans, Sherin Varghese, Alison Turner, Gaurav Agarwal, Jemma Larham, Nathanael Gray, Oluremi Carty, Joe Barrett, Stella Bowcock, Udo Oppermann, Vicky Gamble, Curly T C M Morris, Chara Kyriakou, Mark T Drayson, Supratik Basu, Sarah McDonald, Shelagh McKinley, Sarah Gooding, Muhammad Kassim Javaid, Karthik Ramasamy
Determinants of durable humoral and T cell immunity in myeloma patients following COVID-19 vaccination. European journal of haematology 112 (4) (2023)
Clement Twumasi, Sally Moore, Ross Sadler, Sally Jeans, Sherin Varghese, Alison Turner, Gaurav Agarwal, Jemma Larham, Nathanael Gray, Oluremi Carty, Joe Barrett, Stella Bowcock, Udo Oppermann, Vicky Gamble, Curly T C M Morris, Chara Kyriakou, Mark T Drayson, Supratik Basu, Sarah McDonald, Shelagh McKinley, Sarah Gooding, Muhammad Kassim Javaid, Karthik Ramasamy
Determinants of durable humoral and T cell immunity in myeloma patients following COVID-19 vaccination. European journal of haematology (2023)
Clement Twumasi, Sally Moore, Ross Sadler, Sally Jeans, Sherin Varghese, Alison Turner, Gaurav Agarwal, Jemma Larham, Nathanael Gray, Oluremi Carty, Joe Barrett, Stella Bowcock, Udo Oppermann, Vicky Gamble, Curly T C M Morris, Chara Kyriakou, Mark T Drayson, Supratik Basu, Sarah McDonald, Shelagh McKinley, Sarah Gooding, Muhammad Kassim Javaid, Karthik Ramasamy
Determinants of durable humoral and T cell immunity in myeloma patients following COVID-19 vaccination. European journal of haematology 112 (4) (2023)
Stella Bowcock, Catherine Atkin, Gulnaz Iqbal, Guy Pratt, Kwee Yong, Richard D Neal, Tim Planche, Kamaraj Karunanithi, Stephen Jenkins, Simon Stern, Sarah Arnott, Peter Toth, Farooq A Wandroo, Janet A Dunn, Mark T Drayson, null null
Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) Trial. Cancers 15 (13) (2023)
Akshay Jatin Patel, Zena N Willsmore, Naeem Khan, Alex Richter, Babu Naidu, Mark T Drayson, Sophie Papa, Andrew P Cope, Sophia N Karagiannis, Esperanza Perucha, Gary M Middleton
Regulatory B cell repertoire defects predispose lung cancer patients to immune-related toxicity following checkpoint blockade. Nature communications 13 (1) (2022)
Karthik Ramasamy, Gulnaz Iqbal, Richard Brouwer, Victoria Stalker, Salma Akhtar, Sherin Varghese, Jindriska Lindsay, Stephen Schey, Mark T Drayson, Janet Dunn
Bortezomib, Bendamustine and Dexamethasone vs Thalidomide, Bendamustine and Dexamethasone in Myeloma patients presenting with renal failure (OPTIMAL): a randomised, multi-centre phase II trial. Blood cancer journal 12 (11) (2022)
Ilaria J Chicca, Jennifer L J Heaney, Gulnaz Iqbal, Janet A Dunn, Stella Bowcock, Guy Pratt, Kwee L Yong, Timothy D Planche, Alex Richter, Mark T Drayson
Anti-bacterial antibodies in multiple myeloma patients at disease presentation, in response to therapy and in remission: implications for patient management. Blood cancer journal 10 (11) (2020)
Mark T Drayson, Stella Bowcock, Timothy D Planche, Gulnaz Iqbal, Guy Pratt, Kwee Yong, Jill Wood, Kerry Raynes, Helen B Higgins, Bryony Dawkins, David M Meads, Claire T Hulme, Anna C Phillips, Peter Hawkey, Eric Low, Janet A Dunn
Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT. Health technology assessment (Winchester, England) 23 (62) (2020)
James Croft, Sidra Ellis, Amy L Sherborne, Kim Sharp, Amy Price, Matthew W Jenner, Mark T Drayson, Roger G Owen, Sally Chown, Jindriska Lindsay, Kamaraj Karunanithi, Hannah Hunter, Walter Martin Gregory, Faith E Davies, Gareth J Morgan, Curly T C M Morris, Lilit Atanesyan, Suvi Savola, David A Cairns, Graham Jackson, Richard S Houlston, Martin F Kaiser
Copy number evolution and its relationship with patient outcome-an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial. Leukemia 35 (7) (2020)

Mark T Drayson.css-eqlu8i{font-size:small;padding-left:4px;} (M T Drayson, Mark Drayson)

Publication Activity (10 Years)

Top Topics

Top Venues

Mark T Drayson (M T Drayson, Mark Drayson)